Shanmuga Hospital
add_icon

Shanmuga Hospital

41.39
+2.09
(5.32%)
Market Cap
56.35 Cr
PE Ratio
12.72
Volume
2,000.00
Day High - Low
41.39 - 41.39
52W High-Low
56.76 - 31.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
56.35 Cr
EPS
4.03
PE Ratio
12.72
PB Ratio
1.35
Book Value
29.16
EBITDA
8.50
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
10.60
Debt to Equity
0.29
Forecast For
Actual

Company News

View All News
Caret
neutral
Shanmuga Hospital Limited submits quarterly certificate under SEBI Depositories Regulations for Q1 2026, confirming no dematerialisation requests received during January-March 2026 period.
neutral
Dr. Vaishak M. L., Chief Operating Officer of Shanmuga Hospital Limited, has resigned to pursue growth opportunities outside the organization, effective March 21, 2026.
positive
Shanmuga Hospital Limited announces appointment of Dr. Mehak Jamwal as Assistant Vice President - Operations effective March 16, 2026, bringing 10 years healthcare experience.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,481.50
#1 1,07,572.49
57.03
#1 21,994.30
14.76
#1 1,505
36.08
51.45
954.95
92,929.53
64.50
0.00
#1 28.68
0
26.01
40.33
850.05
64,175.22
64.68
7,849.70
13.25
809
-22.38
52.03
1,728.20
35,317.63
45.07
5,575.00
12.29
790
-34.33
53.48
668.10
34,615.67
96.17
4,286.70
15.12
337
-8.85
54.88
1,050.40
28,233.74
55.37
3,771.40
12.59
481
-33.52
50.51
662.00
26,489.20
84.42
3,067.00
21.98
415
-43.89
52.52
435.05
13,782.71
83.89
1,757.00
27.64
110
#1 54.61
52.40
1,254.00
12,735.52
49.67
1,566.90
17.46
244
7.26
63.64
5,338.65
12,223.38
#1 25.02
599.90
11.69
58
12.46
55.79
Growth Rate
Revenue Growth
10.83 %
Net Income Growth
-19.23 %
Cash Flow Change
-231.94 %
ROE
-65.39 %
ROCE
-60.25 %
EBITDA Margin (Avg.)
-14.55 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
42
40
43
48
0
Expenses
32
32
34
40
0
EBITDA
9
7
9
9
0
Operating Profit %
22 %
19 %
20 %
17 %
0 %
Depreciation
0
1
1
2
0
Interest
0
0
1
1
0
Profit Before Tax
9
7
7
6
0
Tax
2
2
2
2
0
Net Profit
7
5
5
4
0
EPS in ₹
6.91
4.90
5.36
4.03
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
11
23
34
53
Fixed Assets
2
10
16
22
Current Assets
8
13
14
30
Capital Work in Progress
0
0
4
0
Investments
0
0
0
0
Other Assets
8
13
14
30
Total Equity & Liabilities
11
23
34
53
Current Liabilities
4
7
13
9
Non Current Liabilities
0
4
4
4
Total Equity
7
12
17
40
Reserve & Surplus
7
12
7
26
Share Capital
0
0
10
14

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
2
-1
-1
Investing Activities
-2
-8
-12
-5
Operating Activities
2
3
10
-13
Financing Activities
0
7
1
16

Share Holding

% Holding
Dec 2024
Feb 2025
Mar 2025
Sept 2025
Promoter
71.95 %
71.95 %
72.11 %
72.06 %
FIIs
0.00 %
0.00 %
0.19 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.92 %
25.92 %
24.48 %
24.76 %
Others
2.13 %
2.13 %
3.22 %
3.19 %
No of Share Holders
1,772
9
1,449
1,156

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 38.10 38.50
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 45.65 48.00
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 42.50 42.65

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201820 hrs ago
Closure of Trading WindowMar 23, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 21, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 13, 2026
Intimation Regarding Commissioning And Operationalisation Of Litho Evo Laser MachineJan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 28, 2025
Statement On Deviation Or VariationNov 12, 2025
Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Board Meeting Intimation for To Approve The Unaudited Financial Results For The Half Year Ended On 30Th September 2025Nov 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 08, 2025
Shanmuga Hospital Limited Honoured At Times Healthcare Achievers - Tamil Nadu 2025 For Contribution To HealthcareSep 30, 2025
Closure Of Shanmuga ClinicsSep 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 25, 2025
Closure of Trading WindowSep 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 22, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Intimation Of Book Closure For The Purpose Of 05Th Annual General Meeting Of The Company.Sep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Reg. 34 (1) Annual Report.Aug 25, 2025
Notice Of The 05Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 19Th September 2025 At 03.00 P.M. Through Video Conference Or Other Audio Visual Means.Aug 25, 2025
Intimation Regarding Commissioning And Operationalization Of PH Impedance & Manometry SystemAug 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Intimation Regarding Operationalization Of CT ScannerAug 06, 2025
Board Meeting Intimation for To Fix The Date Of AGMAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
CLOSURE OF PHARMACY UNITJun 03, 2025
Statement On Deviation Or VariationMay 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2025
Audited Financial Results For The Financial Year Ended 31St March 2025.May 28, 2025
Board Meeting Outcome for Approval Of Audited Financial Statements For The Financial Year 2024-25May 28, 2025
Board Meeting Intimation for Approving The Audited Financial Results For The Half Year / Year Ended 31St March 2025.May 21, 2025
Intimation Regarding Operationalization Of Robotic Surgical EquipmentMay 11, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Intimation About Change In CIN Of The CompanyApr 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements Regulations) 2015Mar 31, 2025
Intimation Under Regulation 8(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations) For Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025

Technical Indicators

RSI(14)
Neutral
53.60
ATR(14)
Volatile
1.92
STOCH(9,6)
Neutral
41.78
STOCH RSI(14)
Neutral
78.22
MACD(12,26)
Bullish
0.51
ADX(14)
Weak Trend
21.57
UO(9)
Bearish
49.67
ROC(12)
Uptrend And Accelerating
9.47
WillR(14)
Neutral
-33.75